*This event is for Faculty and Staff*
Open to Kennedy Krieger Institute and Johns Hopkins Medical Staff only.
Erika Augustine, MD, MS "Preparing for Therapeutic Discovery in Rare Neurological Diseases – Experiences in Batten Disease Research"
Dr. Erika Augustine is the Director of the Kennedy Krieger Clinical Trials Unit and the Institute’s inaugural Associate Chief Science Officer. Following residency training in Pediatrics and Pediatric Neurology at Harvard University/Boston Children’s Hospital, Dr. Augustine completed dual fellowships in Pediatric Movement Disorders and Experimental Therapeutics at the University of Rochester. She was a member of the University of Rochester faculty for more than a decade prior to starting Kennedy Krieger. Dr. Augustine specializes in the care of children with movement disorders. Her research program focuses on advancing therapeutic development for rare pediatric neurological disorders, with emphasis on comprehensive clinical phenotyping and clinical trial design. Dr. Augustine leads programs developing novel therapeutics for the neuronal ceroid lipofuscinoses (Batten diseases), a group of rare pediatric neurodegenerative disorders. Her current work examines trial readiness of clinical outcomes and digital tools in Batten diseases, and she is the former Co-Director of the University of Rochester Batten Center.
Please note: Grand Rounds Dates & Topics are subject to change. When attending Grand Rounds, all attendees are required to sign in electronically via the instructions and Activity Code provided during the Zoom lecture. Please note, you will have up to 8 hours to claim your credit.
Please contact Angela Wooters Wooters@kennedykrieger.org for questions or assistance.
Zoom link will be provided via Institute correspondence, outlook, and distribution email. Please follow registration instructions provided during Zoom lecture.
Thursday, January 14 at 12:00pm to 1:00pmVirtual Event